American Trust Catalent, Inc. Transaction History

American Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 02, 2022	SELL	$72.36 - $113.1 $528,010 - $825,290	-7,297 Closed	0 $0
Q2 2022 Oct 03, 2022	SELL	$87.2 - $114.05 $214,773 - $280,905	-2,463 Reduced 25.24%	7,297 $783,000
Q1 2022 Jun 08, 2022	SELL	$94.19 - $124.49 $29,952 - $39,587	-318 Reduced 3.16%	9,760 $1.08 Million
Q4 2021 Mar 17, 2022	BUY	$119.57 - $139.07 $1.21 Million - $1.4 Million	10,078 New	10,078 $1.29 Million

512

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.